Evidence map›Paper›PMID 25871318›Full record

ArticleAddiction biology2016

Methamphetamine blunts Ca(2+) currents and excitatory synaptic transmission through D1/5 receptor-mediated mechanisms in the mouse medial prefrontal cortex.

Betina González, Celeste Rivero-Echeto, Javier A Muñiz, Jean Lud Cadet, Edgar García-Rill, Francisco J Urbano, Verónica Bisagno

Open access · greenAbstract read
In one paragraph

Article in Addiction biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. 5-HTInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Betina GonzálezInstituto de Investigaciones Farmacológicas, Universidad de Buenos Aires-Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina.
Celeste Rivero-EchetoLaboratorio de Fisiología y Biología Molecular, Instituto de Fisiología, Biología Molecular y Neurociencias, Departamento de Fisiología, Biología Molecular y Celular 'Dr. Hector Maldonado' (DFBMC), Universidad de Buenos Aires-Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina.
Javier A MuñizInstituto de Investigaciones Farmacológicas, Universidad de Buenos Aires-Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina.
Jean Lud CadetMolecular Neuropsychiatry Research Branch, NIH/NIDA Intramural Research Program, Baltimore, MD, USA.
Edgar García-RillCenter for Translational Neuroscience, Department of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Francisco J UrbanoLaboratorio de Fisiología y Biología Molecular, Instituto de Fisiología, Biología Molecular y Neurociencias, Departamento de Fisiología, Biología Molecular y Celular 'Dr. Hector Maldonado' (DFBMC), Universidad de Buenos Aires-Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina.
Verónica BisagnoInstituto de Investigaciones Farmacológicas, Universidad de Buenos Aires-Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina.
University of Buenos Aires · ARConsejo Nacional de Investigaciones Científicas y Técnicas · ARNational Institute on Drug Abuse · USUniversity of Arkansas for Medical Sciences · US

Funding

Telemedicine CoreP30GM110702 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI GARCIA-RILL, EDGAR E. · 2014 to 2018
$6.1M
Center for Translational NeuroscienceP20GM103425 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI GARCIA-RILL, EDGAR E. · 2012 to 2013
$4.1M
NIGMS NIH HHS P20 GM103425NIGMS NIH HHS P30 GM110702
6 · The paper itself

Abstract

Psychostimulant addiction is associated with dysfunctions in frontal cortex. Previous data demonstrated that repeated exposure to methamphetamine (METH) can alter prefrontal cortex (PFC)-dependent functions. Here, we show that withdrawal from repetitive non-contingent METH administration (7 days, 1 mg/kg) depressed voltage-dependent calcium currents (ICa ) and increased hyperpolarization-activated cation current (IH ) amplitude and the paired-pulse ratio of evoked excitatory postsynaptic currents (EPSCs) in deep-layer pyramidal mPFC neurons. Most of these effects were blocked by systemic co-administration of the D1/D5 receptor antagonist SCH23390 (0.5 and 0.05 mg/kg). In vitro METH (i.e. bath-applied to slices from naïve-treated animals) was able to emulate its systemic effects on ICa and evoked EPSCs paired-pulse ratio. We also provide evidence of altered mRNA expression of (1) voltage-gated calcium channels P/Q-type Cacna1a (Cav 2.1), N-type Cacna1b (Cav 2.2), T-type Cav 3.1 Cacna1g, Cav 3.2 Cacna1h, Cav 3.3 Cacna1i and the auxiliary subunit Cacna2d1 (α2δ1); (2) hyperpolarization-activated cyclic nucleotide-gated channels Hcn1 and Hcn2; and (3) glutamate receptors subunits AMPA-type Gria1, NMDA-type Grin1 and metabotropic Grm1 in the mouse mPFC after repeated METH treatment. Moreover, we show that some of these changes in mRNA expression were sensitive D1/5 receptor blockade. Altogether, these altered mechanisms affecting synaptic physiology and transcriptional regulation may underlie PFC functional alterations that could lead to PFC impairments observed in METH-addicted individuals.

Indexed as

AnimalsBenzazepinesCalciumCalcium ChannelsCalcium Channels, N-TypeCalcium Channels, T-TypeDopamine Uptake InhibitorsHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsMaleMethamphetamineMiceNerve Tissue ProteinsPotassium ChannelsPrefrontal CortexPyramidal CellsReceptors, AMPABenzazepinesCacna1b protein, mouseCacna1g protein, mouseCacna1h protein, mouseCacna1i protein, mouseCACNA2D1 protein, mouseCalciumCalcium ChannelsCalcium Channels, N-TypeCalcium Channels, T-TypeDopamine Uptake InhibitorsGprin1 protein, mouseHcn1 protein, mouseHcn2 protein, mouseHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsMethamphetamineNerve Tissue ProteinsPotassium ChannelsReceptors, AMPAReceptors, Dopamine D1Receptors, Dopamine D5Receptors, N-Methyl-D-AspartateRNA, MessengerSCH 23390Dopamine receptorsglutamatemethamphetamineprefrontal cortexvoltage-gated calcium channels

Identifiers

PMID25871318
PMCPMC4605859
OpenAlexW1936398106

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.